Chemical activators of ZFP61 can be categorized based on their primary mode of action, particularly on how they influence intracellular signaling pathways to lead to the phosphorylation and resultant activation of ZFP61. Forskolin, Isoproterenol, Epinephrine, Cholera Toxin, Dibutyryl-cAMP, 8-Bromo-cAMP, and Glucagon share a common mechanism of increasing cyclic adenosine monophosphate (cAMP) levels within cells. Forskolin does this by directly stimulating adenylate cyclase, while Isoproterenol and Epinephrine bind to beta-adrenergic receptors, and Glucagon interacts with its specific receptor to achieve the same outcome. Cholera Toxin perpetuates the activation of adenylate cyclase by modifying the Gs alpha subunit. The elevated levels of cAMP then activate protein kinase A (PKA), which in turn phosphorylates ZFP61, leading to its activation. Dibutyryl-cAMP and 8-Bromo-cAMP, both analogs of cAMP, bypass cell surface receptors and directly activate PKA, which subsequently phosphorylates ZFP61.
On a different note, PMA and Anisomycin activate ZFP61 through protein kinase C (PKC) and MAP kinase pathways, respectively. PMA functions by directly activating PKC, which can then phosphorylate ZFP61. Anisomycin, on the other hand, triggers the MAP kinase pathways, which can lead to the activation of kinases that phosphorylate ZFP61. Ionomycin and Thapsigargin both act by altering intracellular calcium levels; Ionomycin does this by directly increasing calcium ion permeability, while Thapsigargin inhibits the SERCA pump, both resulting in the activation of calcium-dependent kinases that may phosphorylate ZFP61. Lastly, Okadaic Acid impedes the action of protein phosphatases PP1 and PP2A, leading to a general increase in phosphorylation within the cell, which includes the phosphorylation that activates ZFP61. These diverse chemical activators, despite their varying initial targets and mechanisms, converge on the crucial process of phosphorylating ZFP61, thereby controlling its functional state within the cellular environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin directly activates adenylate cyclase, causing an increase in cAMP levels, which can lead to the activation of protein kinase A (PKA). PKA could then phosphorylate ZFP61, leading to its functional activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol binds to and activates beta-adrenergic receptors, which increases adenylate cyclase activity and cAMP production. The subsequent activation of PKA may result in the phosphorylation and activation of ZFP61. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
Epinephrine engages with adrenergic receptors, stimulating adenylate cyclase and increasing cAMP levels. The activation of PKA that follows can phosphorylate and activate ZFP61. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate ZFP61, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin elevates intracellular calcium levels, which could activate calcium-dependent protein kinases that in turn phosphorylate and activate ZFP61. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This may include phosphorylation events that activate ZFP61. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that directly activates PKA. PKA, once activated, may phosphorylate and activate ZFP61. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin is known to activate MAP kinase pathways, which can lead to activation of kinases that phosphorylate and activate ZFP61. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromo-cAMP is a stable cAMP analog that activates PKA. Once activated, PKA may phosphorylate ZFP61, resulting in its functional activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in intracellular calcium levels. This can activate calcium-dependent kinases that may phosphorylate and activate ZFP61. | ||||||